VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

Running, not enrolling · Phase 4

Conditions studied: Atherosclerotic Cardiovascular Disease

In brief

VictORION-INCLUSION (V-INCLUSION) seeks to evaluate the effectiveness of inclisiran as an innovative therapy with the potential to help bridge care gaps in historically understudied and undertreated populations by leveraging electronic health records (EHR) in multiple US Healthcare Systems (HCS) to systematically identify those at high risk for and already diagnosed with ASCVD for more expeditious achievement of LDL-C targets.

Key facts

Study ID
NCT06249165
Run by
Duke University
People needed
130
Starts
2024-12-16
Expected to finish
2027-02-28
Last updated by the study team
2026-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.